Metabolite-sensing G protein-coupled receptors-facilitators of diet-related immune regulation

Annual Review of Immunology

Volumn 35, Issue , 2017, Pages 371-402

  Tan, Jian K ^a   McKenzie, Craig ^a   Mariño, Eliana ^a   Macia, Laurence ^a,b,c   Mackay, Charles R ^a  

^a MONASH UNIVERSITY   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c University of Sydney   (Australia)

Author keywords

Dietary metabolite; GPR43; Immune regulation; Metabolite sensing GPCR; Western diseases

Indexed keywords

BILE ACID; CYTOKINE; G PROTEIN COUPLED RECEPTOR; G PROTEIN COUPLED RECEPTOR 109A; G PROTEIN COUPLED RECEPTOR 109B; G PROTEIN COUPLED RECEPTOR 120; G PROTEIN COUPLED RECEPTOR 35; G PROTEIN COUPLED RECEPTOR 40; G PROTEIN COUPLED RECEPTOR 41; G PROTEIN COUPLED RECEPTOR 43; G PROTEIN COUPLED RECEPTOR 65; G PROTEIN COUPLED RECEPTOR 84; G PROTEIN COUPLED RECEPTOR 91; G PROTEIN COUPLED RECEPTOR 99; INFLAMMASOME; LIGAND; UNCLASSIFIED DRUG;

ASTHMA; CARDIOVASCULAR DISEASE; DIET; FOOD ALLERGY; HOMEOSTASIS; HUMAN; IMMUNOCOMPETENT CELL; IMMUNOREGULATION; INFLAMMATORY BOWEL DISEASE; INSULIN DEPENDENT DIABETES MELLITUS; INTESTINE EPITHELIUM; MALIGNANT NEOPLASM; METABOLITE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN FUNCTION; REGULATORY T LYMPHOCYTE; REVIEW; SIGNAL TRANSDUCTION; ANIMAL; HYPERSENSITIVITY; IMMUNITY; IMMUNOLOGY; INTESTINE; INTESTINE FLORA; METABOLISM;

ANIMALS; CARDIOVASCULAR DISEASES; DIABETES MELLITUS, TYPE 1; DIET; GASTROINTESTINAL MICROBIOME; HOMEOSTASIS; HUMANS; HYPERSENSITIVITY; IMMUNITY; INFLAMMATORY BOWEL DISEASES; INTESTINES; RECEPTORS, G-PROTEIN-COUPLED;

EID: 85018259615     PISSN: 07320582     EISSN: 15453278     Source Type: Book Series    
DOI: 10.1146/annurev-immunol-051116-052235     Document Type: Review

References (157)

1. Sawzdargo M, George SR, Nguyen T, Xu S, Kolakowski LF, O'Dowd BF. 1997. A cluster of four novel human G protein-coupled receptor genes occurring in close proximity to CD22 gene on chromosome 19q13.1. Biochem. Biophys. Res. Commun. 239:543-47
2. Tan J, McKenzie C, Potamitis M, Thorburn AN, Mackay CR, Macia L. 2014. The role of short-chain fatty acids in health and disease. Adv. Immunol. 121:91-119
3. Zelante T, Iannitti RG, Cunha C, De Luca A, Giovannini G, et al. 2013. Tryptophan catabolites from microbiota engage aryl hydrocarbon receptor and balance mucosal reactivity via interleukin-22. Immunity 39:372-85
4. St-Onge MP, Jones PJ. 2002. Physiological effects of medium-chain triglycerides: potential agents in the prevention of obesity. J. Nutr. 132:329-32
5. Niot I, Poirier H, Tran TT, Besnard P. 2009. Intestinal absorption of long-chain fatty acids: evidence and uncertainties. Prog. Lipid Res. 48:101-15
6. Frost G, Sleeth ML, Sahuri-Arisoylu M, Lizarbe B, Cerdan S, et al. 2014. The short-chain fatty acid acetate reduces appetite via a central homeostatic mechanism. Nat. Commun. 5:3611
7. Page KA, Williamson A, Yu N, McNay EC, Dzuira J, et al. 2009. Medium-chain fatty acids improve cognitive function in intensively treated type 1 diabetic patients and support in vitro synaptic transmission during acute hypoglycemia. Diabetes 58:1237-44
8. Maslowski KM, Vieira AT, Ng A, Kranich J, Sierro F, et al. 2009. Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43. Nature 461:1282-86
9. Oh DY, Talukdar S, Bae EJ, Imamura T, Morinaga H, et al. 2010. GPR120 is an omega-3 fatty acid receptor mediating potent anti-inflammatory and insulin-sensitizing effects. Cell 142:687-98
10. Briscoe CP, Tadayyon M, Andrews JL, Benson WG, Chambers JK, et al. 2003. The orphan G proteincoupled receptor GPR40 is activated by medium and long chain fatty acids. J. Biol. Chem. 278:11303-11
11. Brown AJ, Goldsworthy SM, Barnes AA, Eilert MM, Tcheang L, et al. 2003. The orphan G proteincoupled receptors GPR41 and GPR43 are activated by propionate and other short chain carboxylic acids. J. Biol. Chem. 278:11312-19
12. Le Poul E, Loison C, Struyf S, Springael JY, Lannoy V, et al. 2003. Functional characterization of human receptors for short chain fatty acids and their role in polymorphonuclear cell activation. J. Biol. Chem. 278:25481-89
13. Hirasawa A, TsumayaK, Awaji T, Katsuma S, AdachiT, et al. 2005. Free fatty acids regulate gut incretin glucagon-like peptide-1 secretion through GPR120. Nat. Med. 11:90-94
14. Wang J, Wu X, SimonaviciusN, Tian H, Ling L. 2006. Medium-chain fatty acids as ligands for orphan G protein-coupled receptor GPR84. J. Biol. Chem. 281:34457-64
15. Wang J, Simonavicius N, Wu X, Swaminath G, Reagan J, et al. 2006. Kynurenic acid as a ligand for orphan G protein-coupled receptor GPR35. J. Biol. Chem. 281:22021-28
16. Deng H, Hu H, Fang Y. 2012. Multiple tyrosine metabolites are GPR35 agonists. Sci. Rep. 2:373
17. Lukasova M, Malaval C, Gille A, Kero J, Offermanns S. 2011. Nicotinic acid inhibits progression of atherosclerosis in mice through its receptor GPR109A expressed by immune cells. J. Clin. Investig. 121:1163-73
18. Rubic T, Lametschwandtner G, Jost S, Hinteregger S, Kund J, et al. 2008. Triggering the succinate receptor GPR91 on dendritic cells enhances immunity. Nat. Immunol. 9:1261-69
19. Singh N, Gurav A, Sivaprakasam S, Brady E, Padia R, et al. 2014. Activation of Gpr109a, receptor for niacin and the commensal metabolite butyrate, suppresses colonic inflammation and carcinogenesis. Immunity 40:128-39
20. Venkataraman C, Kuo F. 2005. The G-protein coupled receptor, GPR84 regulates IL-4 production by T lymphocytes in response to CD3 crosslinking. Immunol. Lett. 101:144-53
21. Smith PM, Howitt MR, Panikov N, Michaud M, Gallini CA, et al. 2013. The microbial metabolites, short-chain fatty acids, regulate colonic Treg cell homeostasis. Science 341:569-73
22. Nohr MK, Pedersen MH, Gille A, Egerod KL, Engelstoft MS, et al. 2013. GPR41/FFAR3 and GPR43/FFAR2 as cosensors for short-chain fatty acids in enteroendocrine cells versus FFAR3 in enteric neurons and FFAR2 in enteric leukocytes. Endocrinology 154:3552-64
23. Karaki S, Mitsui R, Hayashi H, Kato I, Sugiya H, et al. 2006. Short-chain fatty acid receptor, GPR43, is expressed by enteroendocrine cells and mucosal mast cells in rat intestine. Cell Tissue Res. 324:353-60
24. Cox MA, Jackson J, Stanton M, Rojas-Triana A, Bober L, et al. 2009. Short-chain fatty acids act as antiinflammatory mediators by regulating prostaglandin E2 and cytokines. World J. Gastroenterol. 15:5549-57
25. Karaki S, Tazoe H, Hayashi H, Kashiwabara H, Tooyama K, et al. 2008. Expression of the short-chain fatty acid receptor, GPR43, in the human colon. J. Mol. Histol. 39:135-42
26. Senga T, Iwamoto S, Yoshida T, Yokota T, Adachi K, et al. 2003. LSSIG is a novel murine leukocytespecific GPCR that is induced by the activation of STAT3. Blood 101:1185-87
27. Mamontov P, Neiman E, Cao T, Perrigoue J, Friedman J, et al. 2015. Effects of short chain fatty acids and GPR43 stimulation on human Treg function (IRC5P.631). J. Immunol. 194:58.14
28. Vinolo MA, Ferguson GJ, Kulkarni S, Damoulakis G, Anderson K, et al. 2011. SCFAs induce mouse neutrophil chemotaxis through the GPR43 receptor. PLOS ONE 6:e21205
29. Macia L, Tan J, Vieira AT, Leach K, Stanley D, et al. 2015. Metabolite-sensing receptors GPR43 and GPR109A facilitate dietary fibre-induced gut homeostasis through regulation of the inflammasome. Nat. Commun. 6:6734
30. Kim M, Kang SG, Park JH, Yanagisawa M, Kim CH. 2014. The commensal bacteria metabolites short chain fatty acids positively regulate epithelial innate immune responses in the gut (MUC4P.847). J. Immunol. 192:133.23.
31. Marino E, Richards JL, McLeod KH, Stanley D, Yap YA, et al. 2017. Gut microbial metabolites limit autoimmune T cell frequencies and protect against type 1 diabetes. Nat. Immunol. In press
32. Kimura I, Ozawa K, Inoue D, Imamura T, Kimura K, et al. 2013. The gut microbiota suppresses insulin-mediated fat accumulation via the short-chain fatty acid receptor GPR43. Nat. Commun. 4:1829
33. McNelis JC, Lee YS, Mayoral R, van der Kant R, Johnson AM, et al. 2015. GPR43 potentiates beta-cell function in obesity. Diabetes 64:3203-17
34. Bahar Halpern K, Veprik A, Rubins N, Naaman O, Walker MD. 2012. GPR41 gene expression is mediated by internal ribosome entry site (IRES)-dependent translation of bicistronic mRNA encoding GPR40 and GPR41 proteins. J. Biol. Chem. 287:20154-63
35. Xiong Y, Miyamoto N, Shibata K, Valasek MA, Motoike T, et al. 2004. Short-chain fatty acids stimulate leptin production in adipocytes through the G protein-coupled receptor GPR41. PNAS 101:1045-50
36. De Vadder F, Kovatcheva-Datchary P, Goncalves D, Vinera J, Zitoun C, et al. 2014. Microbiotagenerated metabolites promote metabolic benefits via gut-brain neural circuits. Cell 156:84-96
37. Trompette A, Gollwitzer ES, Yadava K, Sichelstiel AK, Sprenger N, et al. 2014. Gut microbiota metabolism of dietary fiber influences allergic airway disease and hematopoiesis. Nat. Med. 20:159-66
38. Puhl HL 3rd, Won YJ, Lu VB, Ikeda SR. 2015. Human GPR42 is a transcribed multisite variant that exhibits copy number polymorphism and is functional when heterologously expressed. Sci. Rep. 5:12880
39. Thangaraju M, Cresci GA, Liu K, Ananth S, Gnanaprakasam JP, et al. 2009. GPR109A is a G-proteincoupled receptor for the bacterial fermentation product butyrate and functions as a tumor suppressor in colon. Cancer Res. 69:2826-32
40. Digby JE, Martinez F, Jefferson A, Ruparelia N, Chai J, et al. 2012. Anti-inflammatory effects of nicotinic acid in humanmonocytes aremediated by GPR109A dependentmechanisms. Arterioscler. Thromb. Vasc. Biol. 32:669-76
41. Zandi-Nejad K, Takakura A, Jurewicz M, Chandraker AK, Offermanns S, et al. 2013. The role ofHCA2 (GPR109A) in regulating macrophage function. FASEB J. 27:4366-74
42. Digby JE, McNeill E, Dyar OJ, Lam V, Greaves DR, Choudhury RP. 2010. Anti-inflammatory effects of nicotinic acid in adipocytes demonstrated by suppression of fractalkine, RANTES, and MCP-1 and upregulation of adiponectin. Atherosclerosis 209:89-95
43. Gambhir D, Ananth S, Veeranan-Karmegam R, Elangovan S, Hester S, et al. 2012. GPR109A as an anti-inflammatory receptor in retinal pigment epithelial cells and its relevance to diabetic retinopathy. Investig. Ophthalmol. Vis. Sci. 53:2208-17
44. Tang Y, Chen Y, Jiang H, Robbins GT, Nie D. 2011. G-protein-coupled receptor for short-chain fatty acids suppresses colon cancer. Int. J. Cancer 128:847-56
45. Irukayama-Tomobe Y, Tanaka H, Yokomizo T, Hashidate-Yoshida T, Yanagisawa M, Sakurai T. 2009. Aromatic D-amino acids act as chemoattractant factors for human leukocytes through a G proteincoupled receptor, GPR109B. PNAS 106:3930-34
46. Ahmed K, Tunaru S, Langhans CD, Hanson J, Michalski CW, et al. 2009. Deorphanization of GPR109B as a receptor for the beta-oxidation intermediate 3-OH-octanoic acid and its role in the regulation of lipolysis. J. Biol. Chem. 284:21928-33
47. Suzuki M, Takaishi S, Nagasaki M, Onozawa Y, Iino I, et al. 2013. Medium-chain fatty acid-sensing receptor, GPR84, is a proinflammatory receptor. J. Biol. Chem. 288:10684-91
48. Nagasaki H, Kondo T, Fuchigami M, Hashimoto H, Sugimura Y, et al. 2012. Inflammatory changes in adipose tissue enhance expression of GPR84, a medium-chain fatty acid receptor: TNFaenhances GPR84 expression in adipocytes. FEBS Lett. 586:368-72
49. Bouchard C, Page J, Bedard A, Tremblay P, Vallieres L. 2007. G protein-coupled receptor 84, a microglia-associated protein expressed in neuroinflammatory conditions. Glia 55:790-800
50. Itoh Y, Kawamata Y, Harada M, Kobayashi M, Fujii R, et al. 2003. Free fatty acids regulate insulin secretion from pancreatic beta cells through GPR40. Nature 422:173-76
51. Li M, Meng X, Xu J, Huang X, Li H, et al. 2016. GPR40 agonist ameliorates liver X receptor-induced lipid accumulation in liver by activating AMPK pathway. Sci. Rep. 6:25237
52. Fujita T, Matsuoka T, Honda T, Kabashima K, Hirata T, Narumiya S. 2011.AGPR40 agonistGW9508 suppresses CCL5, CCL17, and CXCL10 induction in keratinocytes and attenuates cutaneous immune inflammation. J. Invest. Dermatol. 131:1660-67
53. Mobraten K, Haug TM, Kleiveland CR, Lea T. 2013. Omega-3 and omega-6 PUFAs induce the same GPR120-mediated signalling events, but with different kinetics and intensity in Caco-2 cells. Lipids Health Dis. 12:101
54. Calder PC. 2005. Polyunsaturated fatty acids and inflammation. Biochem. Soc. Trans. 33:423-27
55. Simopoulos AP. 2002. Omega-3 fatty acids in inflammation and autoimmune diseases. J. Am. Coll. Nutr. 21:495-505
56. Estruch R, Ros E, Salas-Salvado J, Covas MI, Corella D, et al. 2013. Primary prevention of cardiovascular disease with a Mediterranean diet. N. Engl. J. Med. 368:1279-90
57. Iwasaki K, Harada N, Sasaki K, Yamane S, Iida K, et al. 2015. Free fatty acid receptor GPR120 is highly expressed in enteroendocrine K cells of the upper small intestine and has a critical role in GIP secretion after fat ingestion. Endocrinology 156:837-46
58. Konno Y, Ueki S, Takeda M, Kobayashi Y, Tamaki M, et al. 2015. Functional analysis of free fatty acid receptor GPR120 in human eosinophils: implications in metabolic homeostasis. PLOS ONE 10:e0120386
59. Anbazhagan AN, Priyamvada S, Gujral T, Bhattacharyya S, Alrefai WA, et al. 2016. A novel antiinflammatory role of GPR120 in intestinal epithelial cells. Am. J. Physiol. Cell Physiol. 310:C612-21
60. Jostins L, Ripke S, Weersma RK, Duerr RH, McGovern DP, et al. 2012. Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature 491:119-24
61. Hubbard TD, Murray IA, Perdew GH. 2015. Indole and tryptophan metabolism: endogenous and dietary routes to Ah receptor activation. Drug Metab. Dispos. 43:1522-35
62. Maravillas-Montero JL, Burkhardt AM, Hevezi PA, Carnevale CD, Smit MJ, Zlotnik A. 2015. Cutting edge: GPR35/CXCR8 is the receptor of the mucosal chemokine CXCL17. J. Immunol. 194:29-33
63. He W, Miao FJ, Lin DC, Schwandner RT, Wang Z, et al. 2004. Citric acid cycle intermediates as ligands for orphan G-protein-coupled receptors. Nature 429:188-93
64. Littlewood-Evans A, Sarret S, Apfel V, Loesle P, Dawson J, et al. 2016. GPR91 senses extracellular succinate released from inflammatory macrophages and exacerbates rheumatoid arthritis. J. Exp. Med. 213:1655-62
65. Ishii S, Kihara Y, Shimizu T. 2005. Identification of T cell death-associated gene 8 (TDAG8) as a novel acid sensing G-protein-coupled receptor. J. Biol. Chem. 280:9083-87
66. Im D-S, Heise CE, Nguyen T, O'Dowd BF, Lynch KR. 2001. Identification of a molecular target of psychosine and its role in globoid cell formation. J. Cell Biol. 153:429-34
67. Kyaw H, Zeng Z, Su K, Fan P, Shell BK, et al. 1998. Cloning, characterization, and mapping of human homolog of mouse T-cell death-associated gene. DNA Cell Biol. 17:493-500
68. Kottyan LC, Collier AR, Cao KH, Niese KA, Hedgebeth M, et al. 2009. Eosinophil viability is increased by acidic pH in a cAMP-and GPR65-dependent manner. Blood 114:2774-82
69. Zhu X, Mose E, Hogan SP, Zimmermann N. 2014. Differential eosinophil and mast cell regulation: Mast cell viability and accumulation in inflammatory tissue are independent of proton-sensing receptor GPR65. Am. J. Physiol. Gastrointest. Liver Physiol. 306:G974-82
70. Choi JW, Lee SY, Choi Y. 1996. Identification of a putativeGprotein-coupled receptor induced during activation-induced apoptosis of T cells. Cell Immunol. 168:78-84
71. Tosa N, Murakami M, Jia WY, Yokoyama M, Masunaga T, et al. 2003. Critical function of T cell death-associated gene 8 in glucocorticoid-induced thymocyte apoptosis. Int. Immunol. 15:741-49
72. Ryder C, McColl K, Zhong F, Distelhorst CW. 2012. Acidosis promotes Bcl-2 family-mediated evasion of apoptosis: involvement of acid-sensing G protein-coupled receptor GPR65 signaling toMEK/ERK. J. Biol. Chem. 287:27863-75
73. Rosko AE, McColl KS, Zhong F, Ryder CB, Chang MJ, et al. 2014. Acidosis sensing receptor GPR65 correlates with anti-apoptotic Bcl-2 family member expression in CLL cells: potential implications for the CLL microenvironment. J. Leuk. 2:160
74. Franke A, McGovern DPB, Barrett JC, Wang K, Radford-Smith GL, et al. 2010. Genome-wide metaanalysis increases to 71 the number of confirmedCrohn's disease susceptibility loci. Nat.Genet. 42:1118-25
75. Ke X. 2012. Presence of multiple independent effects in risk loci of common complex human diseases. Am. J. Hum. Genet. 91:185-92
76. Ballester V, Guo X, Vendrell R, Haritunians T, Klomhaus AM, et al. 2014. Association of NOD2 and IL23R with inflammatory bowel disease in Puerto Rico. PLOS ONE 9:e108204
77. Lassen KG, McKenzie CI, Mari M, Murano T, Begun J, et al. 2016. Genetic coding variant in GPR65 alters lysosomal pH and links lysosomal dysfunction with colitis risk. Immunity 44:1392-1405
78. Brestoff JR, Artis D. 2013. Commensal bacteria at the interface of host metabolism and the immune system. Nat. Immunol. 14:676-84
79. Ding L, Yang L, Wang Z, HuangW. 2015. Bile acid nuclear receptorFXRand digestive system diseases. Acta Pharm. Sin. B 5:135-44
80. Wahlstrom A, Sayin SI, Marschall H-U, Backhed F. 2016. Intestinal crosstalk between bile acids and microbiota and its impact on host metabolism. Cell Metab. 24:41-50
81. Duboc H, Tache Y, Hofmann AF. 2014. The bile acid TGR5 membrane receptor: from basic research to clinical application. Dig. Liver. Dis. 46:302-12
82. Cipriani S, Mencarelli A, Chini MG, Distrutti E, Renga B, et al. 2011. The bile acid receptor GPBAR-1 (TGR5) modulates integrity of intestinal barrier and immune response to experimental colitis. PLOS ONE 6:e25637
83. Perino A, Pols TW, Nomura M, Stein S, Pellicciari R, Schoonjans K. 2014. TGR5 reduces macrophage migration through mTOR-induced C/EBPβdifferential translation. J. Clin. Investig. 124:5424-36
84. Guo C, Xie S, Chi Z, Zhang J, Liu Y, et al. 2016. Bile acids control inflammation andmetabolic disorder through inhibition of NLRP3 inflammasome. Immunity 45:944
85. Swann JR, Want EJ, Geier FM, Spagou K, Wilson ID, et al. 2011. Systemic gut microbial modulation of bile acid metabolism in host tissue compartments. PNAS. 108(Suppl. 1):4523-30
86. Liu C, Wu J, Zhu J, Kuei C, Yu J, et al. 2009. Lactate inhibits lipolysis in fat cells through activation of an orphan G-protein-coupled receptor, GPR81. J. Biol. Chem. 284:2811-22
87. Ljungh A, Wadstrom T. 2006. Lactic acid bacteria as probiotics. Curr. Issues Intest. Microbiol. 7:73-89
88. Khor B, Gardet A, Xavier RJ. 2011. Genetics and pathogenesis of inflammatory bowel disease. Nature 474:307-17
89. de Valliere C, Wang Y, Eloranta JJ, Vidal S, Clay I, et al. 2015.Gprotein-coupled pH-sensing receptor OGR1 is a regulator of intestinal inflammation. Inflamm. Bowel Dis. 21:1269-81
90. Cohen LJ, Kang HS, Chu J, Huang YH, Gordon EA, et al. 2015. Functional metagenomic discovery of bacterial effectors in the human microbiome and isolation of commendamide, a GPCR G2A/132 agonist. PNAS 112:E4825-34
91. Obinata H, Hattori T, Nakane S, Tatei K, Izumi T. 2005. Identification of 9-hydroxyoctadecadienoic acid and other oxidized free fatty acids as ligands of the G protein-coupled receptor G2A. J. Biol. Chem. 280:40676-83
92. Guo Y, Zhang W, Giroux C, Cai Y, Ekambaram P, et al. 2011. Identification of the orphan G protein-coupled receptor GPR31 as a receptor for 12-(S)-hydroxyeicosatetraenoic acid. J. Biol. Chem. 286:33832-40
93. Hosoi T, Koguchi Y, Sugikawa E, Chikada A, Ogawa K, et al. 2002. Identification of a novel human eicosanoid receptor coupled to Gi/o. J. Biol. Chem. 277:31459-65
94. Krishnamoorthy S, Recchiuti A, ChiangN, Yacoubian S, LeeCH, et al. 2010. Resolvin D1 binds human phagocytes with evidence for proresolving receptors. PNAS 107:1660-65
95. Schmid M, Gemperle C, Rimann N, Hersberger M. 2016. Resolvin D1 polarizes primary human macrophages toward a proresolution phenotype through GPR32. J. Immunol. 196:3429-37
96. Godlewski G, Offertaler L, Wagner JA, Kunos G. 2009. Receptors for acylethanolamides-GPR55 and GPR119. Prostaglandins Other Lipid Mediat. 89:105-11
97. Henstridge CM, Balenga NA, Ford LA, Ross RA, Waldhoer M, Irving AJ. 2009. The GPR55 ligand L-a-lysophosphatidylinositol promotes RhoA-dependent Ca2+ signaling and NFAT activation. FASEB J. 23:183-93
98. Kim SV, Xiang WV, Kwak C, Yang Y, Lin XW, et al. 2013. GPR15-mediated homing controls immune homeostasis in the large intestine mucosa. Science 340:1456-59
99. Gardner J, Wu S, Ling L, Danao J, Li Y, et al. 2012. G-protein-coupled receptor GPR21 knockout mice display improved glucose tolerance and increased insulin response. Biochem. Biophys. Res. Commun. 418:1-5
100. Osborn O, Oh DY, McNelis J, Sanchez-Alavez M, Talukdar S, et al. 2012. G protein-coupled receptor 21 deletion improves insulin sensitivity in diet-induced obese mice. J. Clin. Investig. 122:2444-53
101. Isberg V, Andersen KB, Bisig C, Dietz GP, Brauner-Osborne H, Gloriam DE. 2014. Computer-aided discovery of aromatic L-a-amino acids as agonists of the orphan G protein-coupled receptor GPR139. J. Chem. Inf. Model. 54:1553-57
102. Gao H, Sun Y, Wu Y, Luan B, Wang Y, et al. 2004. Identification ofβ-arrestin2 as aGprotein-coupled receptor-stimulated regulator of NF-κB pathways. Mol. Cell 14:303-17
103. Lee SU, In HJ, Kwon MS, Park BO, Jo M, et al. 2013. β-Arrestin 2 mediates G protein-coupled receptor 43 signals to nuclear factor-κB. Biol. Pharm. Bull. 36:1754-59
104. Chai JT, Digby JE, Choudhury RP. 2013. GPR109A and vascular inflammation. Curr. Atheroscler. Rep. 15:325
105. Violin JD, Lefkowitz RJ. 2007. β-Arrestin-biased ligands at seven-transmembrane receptors. Trends Pharmacol. Sci. 28:416-22
106. Kim HY, Jadhav VB, Jeong DY, Park WK, Song JH, et al. 2015. Discovery of 4-(phenyl)thio-1Hpyrazole derivatives as agonists of GPR109A, a high affinity niacin receptor. Arch. Pharm. Res. 38:1019-32
107. Walters RW, Shukla AK, Kovacs JJ, Violin JD, DeWire SM, et al. 2009.β-Arrestin1mediates nicotinic acid-induced flushing, but not its antilipolytic effect, in mice. J. Clin. Investig. 119:1312-21
108. Tedelind S, Westberg F, Kjerrulf M, Vidal A. 2007. Anti-inflammatory properties of the short-chain fatty acids acetate and propionate: a study with relevance to inflammatory bowel disease. World J. Gastroenterol. 13:2826-32
109. Place RF, Noonan EJ, Giardina C. 2005. HDAC inhibition prevents NF-κB activation by suppressing proteasome activity: Down-regulation of proteasome subunit expression stabilizes Iκβa. Biochem. Pharmacol. 70:394-406
110. Xu X, Ye L, Araki K, Ahmed R. 2012. mTOR, linking metabolism and immunity. Semin. Immunol. 24:429-35
111. Park J, Kim M, Kang SG, Jannasch AH, Cooper B, et al. 2015. Short-chain fatty acids induce both effector and regulatory T cells by suppression of histone deacetylases and regulation of the mTOR-S6K pathway. Mucosal Immunol. 8:80-93
112. Elinav E, Strowig T, Kau AL, Henao-Mejia J, Thaiss CA, et al. 2011. NLRP6 inflammasome regulates colonic microbial ecology and risk for colitis. Cell 145:745-57
113. Lee GS, Subramanian N, Kim AI, Aksentijevich I, Goldbach-Mansky R, et al. 2012. The calciumsensing receptor regulates the NLRP3 inflammasome through Ca2+ and cAMP. Nature 492:123-27
114. Murakami T, Ockinger J, Yu J, Byles V, McColl A, et al. 2012. Critical role for calcium mobilization in activation of the NLRP3 inflammasome. PNAS 109:11282-87
115. Kahlenberg JM, Dubyak GR. 2004. Mechanisms of caspase-1 activation by P2X7 receptor-mediated K+ release. Am. J. Physiol. Cell Physiol. 286:C1100-8
116. Munoz-Planillo R, Kuffa P, Martinez-Colon G, Smith BL, Rajendiran TM, Nunez G. 2013. K+ efflux is the common trigger of NLRP3 inflammasome activation by bacterial toxins and particulate matter. Immunity 38:1142-53
117. Vieira AT, Macia L, Galvao I, Martins FS, Canesso MC, et al. 2015. A role for gut microbiota and the metabolite-sensing receptor GPR43 in a murine model of gout. Arthritis Rheumatol. 67:1646-56
118. Arpaia N, Campbell C, Fan X, Dikiy S, van der Veeken J, et al. 2013. Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation. Nature 504:451-55
119. Furusawa Y, Obata Y, Fukuda S, Endo TA, Nakato G, et al. 2013. Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells. Nature 504:446-50
120. Tan J, McKenzie C, Vuillermin PJ, Goverse G, Vinuesa CG, et al. 2016. Dietary fiber and bacterial SCFA enhance oral tolerance and protect against food allergy through diverse cellular pathways. Cell Rep. 15:2809-24
121. Kamp ME, Shim R, Nicholls AJ, Oliverira AC, Mason LJ, et al. 2016. G protein-coupled receptor 43 modulates neutrophil recruitment during acute inflammation. PLOS ONE 11(9):e0163750
122. Barth MC, Ahluwalia N, Anderson TJ, Hardy GJ, Sinha S, et al. 2009. Kynurenic acid triggers firm arrest of leukocytes to vascular endothelium under flow conditions. J. Biol. Chem. 284:19189-95
123. Li J, Wang Y, Tang L, de Villiers WJ, Cohen D, et al. 2013. Dietary medium-chain triglycerides promote oral allergic sensitization and orally induced anaphylaxis to peanut protein in mice. J. Allergy Clin. Immunol. 131:442-50
124. Perez CJ, Dumas A, Vallieres L, Guenet JL, Benavides F. 2013. Several classical mouse inbred strains, including DBA/2, NOD/Lt, FVB/N, and SJL/J, carry a putative loss-of-function allele of Gpr84. J. Hered. 104:565-71
125. Sapieha P, Sirinyan M, Hamel D, Zaniolo K, Joyal JS, et al. 2008. The succinate receptor GPR91 in neurons has a major role in retinal angiogenesis. Nat. Med. 14:1067-76
126. Tannahill GM, Curtis AM, Adamik J, Palsson-McDermott EM, McGettrick AF, et al. 2013. Succinate is an inflammatory signal that induces IL-1beta through HIF-1alpha. Nature 496:238-42
127. Harig JM, Soergel KH, Komorowski RA, Wood CM. 1989. Treatment of diversion colitis with shortchain-fatty acid irrigation. N. Engl. J. Med. 320:23-8
128. Steinhart AH, Brzezinski A, Baker JP. 1994. Treatment of refractory ulcerative proctosigmoiditis with butyrate enemas. Am. J. Gastroenterol. 89:179-83
129. Scheppach W, Sommer H, Kirchner T, Paganelli GM, Bartram P, et al. 1992. Effect of butyrate enemas on the colonic mucosa in distal ulcerative colitis. Gastroenterology 103:51-6
130. Butzner JD, Parmar R, Bell CJ, Dalal V. 1996. Butyrate enema therapy stimulates mucosal repair in experimental colitis in the rat. Gut 38:568-73
131. Huda-FaujanN, Abdulamir AS, Fatimah AB, AnasOM, ShuhaimiM, et al. 2010. The impact of the level of the intestinal short chain fatty acids in inflammatory bowel disease patients versus healthy subjects. Open Biochem. J. 4:53-58
132. Segain JP, Raingeard de la Bletiere D, Bourreille A, Leray V, Gervois N, et al. 2000. Butyrate inhibits inflammatory responses through NFκB inhibition: implications for Crohn's disease. Gut 47:397-403
133. Luhrs H, Gerke T, Boxberger F, Backhaus K, Melcher R, et al. 2001. Butyrate inhibits interleukin-1-mediated nuclear factor-kappa B activation in human epithelial cells. Dig. Dis. Sci. 46:1968-73
134. Yin L, Laevsky G, Giardina C. 2001. Butyrate suppression of colonocyte NF-κB activation and cellular proteasome activity. J. Biol. Chem. 276:44641-46
135. Fukuda S, Toh H, Hase K, Oshima K, Nakanishi Y, et al. 2011. Bifidobacteria can protect from enteropathogenic infection through production of acetate. Nature 469:543-47
136. Olszak T, An D, Zeissig S, Vera MP, Richter J, et al. 2012. Microbial exposure during early life has persistent effects on natural killer T cell function. Science 336:489-93
137. Herbst T, Sichelstiel A, Schar C, Yadava K, Burki K, et al. 2011. Dysregulation of allergic airway inflammation in the absence of microbial colonization. Am. J. Respir. Crit. Care Med. 184:198-205
138. Perry RJ, Peng L, Barry NA, Cline GW, Zhang D, et al. 2016. Acetate mediates a microbiome-brainbeta-cell axis to promote metabolic syndrome. Nature 534:213-17
139. Tang C, Ahmed K, Gille A, Lu S, Grone HJ, et al. 2015. Loss of FFA2 and FFA3 increases insulin secretion and improves glucose tolerance in type 2 diabetes. Nat. Med. 21:173-77
140. Thorburn AN, McKenzie CI, Shen S, Stanley D, Macia L, et al. 2015. Evidence that asthma is a developmental origin disease influenced by maternal diet and bacterial metabolites. Nat. Commun. 6:7320
141. Stefka AT, Feehley T, Tripathi P, Qiu J, McCoy K, et al. 2014. Commensal bacteria protect against food allergen sensitization. PNAS 111:13145-50
142. Hinterleitner R, Jabri B. 2016. A dendritic cell subset designed for oral tolerance. Nat. Immunol. 17:474-76
143. Park Y, Subar AF, Hollenbeck A, Schatzkin A. 2011. Dietary fiber intake and mortality in the NIHAARP diet and health study. Arch. Intern. Med. 171:1061-68
144. Marques FZ, Nelson EM, Chu P-Y, Horlock D, Fiedler A, et al. 2011. High fibre diet and acetate supplementation change the gut microbiota and prevent the development of hypertension and heart failure in DOCA-salt hypertensive mice. Circulation. In press. https://doi.org/10.1161/ CIRCULATIONAHA.116.024545
145. Ignarro LJ, Balestrieri ML, Napoli C. 2007. Nutrition, physical activity, and cardiovascular disease: an update. Cardiovasc. Res. 73:326-40
146. Ou J, Carbonero F, Zoetendal EG, DeLany JP, Wang M, et al. 2013. Diet, microbiota, and microbial metabolites in colon cancer risk in rural Africans and African Americans. Am. J. Clin. Nutr. 98:111-20
147. Bindels LB, Porporato P, Dewulf EM, Verrax J, Neyrinck AM, et al. 2012. Gut microbiota-derived propionate reduces cancer cell proliferation in the liver. Br. J. Cancer 107:1337-44
148. Wu Q, Wang H, Zhao X, Shi Y, Jin M, et al. 2013. Identification of G-protein-coupled receptor 120 as a tumor-promoting receptor that induces angiogenesis and migration in human colorectal carcinoma. Oncogene 32:5541-50
149. Wen L, Ley RE, Volchkov PY, Stranges PB, Avanesyan L, et al. 2008. Innate immunity and intestinal microbiota in the development of type 1 diabetes. Nature 455:1109-13
150. Markle JG, Frank DN, Mortin-Toth S, Robertson CE, Feazel LM, et al. 2013. Sex differences in the gut microbiome drive hormone-dependent regulation of autoimmunity. Science 339:1084-88
151. Ziegler AG, Rewers M, Simell O, Simell T, Lempainen J, et al. 2013. Seroconversion to multiple islet autoantibodies and risk of progression to diabetes in children. JAMA 309:2473-79
152. McKenzie CI, Mackay CR, Macia L. 2015. GPR43-a prototypic metabolite sensor linking metabolic and inflammatory diseases. Trends Endocrinol. Metab. 26:511-12
153. Maslowski KM, Mackay CR. 2011. Diet, gut microbiota and immune responses. Nat. Immunol. 12:5-9
154. Kamanna VS, Ganji SH, Kashyap ML. 2009. Themechanism andmitigation of niacin-induced flushing. Int. J. Clin. Pract. 63:1369-77
155. Thorburn AN, Macia L, Mackay CR. 2014. Diet, metabolites, and "western-lifestyle" inflammatory diseases. Immunity 40:833-42
156. Oka S, Ota R, Shima M, Yamashita A, Sugiura T. 2010. GPR35 is a novel lysophosphatidic acid receptor. Biochem. Biophys. Res. Commun. 395:232-37
157. Hakak Y, Lehmann-Bruinsma K, Phillips S, Le T, Liaw C, et al. 2009. The role of the GPR91 ligand succinate in hematopoiesis. J. Leukoc. Biol. 85:837-43